Anti-STARD3NL monoclonal antibody

Pre-made anti-STARD3NL monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STARD3NL/STARD3NL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1840-Ab-1/ GM-Tg-hg-IP1840-Ab-2Anti-Human STARD3NL monoclonal antibodyHuman
GM-Tg-rg-IP1840-Ab-1/ GM-Tg-rg-IP1840-Ab-2Anti-Rat STARD3NL monoclonal antibodyRat
GM-Tg-mg-IP1840-Ab-1/ GM-Tg-mg-IP1840-Ab-2Anti-Mouse STARD3NL monoclonal antibodyMouse
GM-Tg-cynog-IP1840-Ab-1/ GM-Tg-cynog-IP1840-Ab-2Anti-Cynomolgus/ Rhesus macaque STARD3NL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1840-Ab-1/ GM-Tg-felg-IP1840-Ab-2Anti-Feline STARD3NL monoclonal antibodyFeline
GM-Tg-cang-IP1840-Ab-1/ GM-Tg-cang-IP1840-Ab-2Anti-Canine STARD3NL monoclonal antibodyCanine
GM-Tg-bovg-IP1840-Ab-1/ GM-Tg-bovg-IP1840-Ab-2Anti-Bovine STARD3NL monoclonal antibodyBovine
GM-Tg-equg-IP1840-Ab-1/ GM-Tg-equg-IP1840-Ab-2Anti-Equine STARD3NL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1840-Ab-1/ GM-Tg-hg-IP1840-Ab-2; GM-Tg-rg-IP1840-Ab-1/ GM-Tg-rg-IP1840-Ab-2;
GM-Tg-mg-IP1840-Ab-1/ GM-Tg-mg-IP1840-Ab-2; GM-Tg-cynog-IP1840-Ab-1/ GM-Tg-cynog-IP1840-Ab-2;
GM-Tg-felg-IP1840-Ab-1/ GM-Tg-felg-IP1840-Ab-2; GM-Tg-cang-IP1840-Ab-1/ GM-Tg-cang-IP1840-Ab-2;
GM-Tg-bovg-IP1840-Ab-1/ GM-Tg-bovg-IP1840-Ab-2; GM-Tg-equg-IP1840-Ab-1/ GM-Tg-equg-IP1840-Ab-2
Products NameAnti-STARD3NL monoclonal antibody
Formatmab
Target NameSTARD3NL
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STARD3NL monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1840-Ag-1Recombinant multi-species STR3N/ STARD3NL/ MENTHO protein
    ORF Viral VectorvGMLP000694human STARD3NL Lentivirus particle
    ORF Viral VectorpGMLP000694human STARD3NL Lentivirus plasmid


    Target information

    Target IDGM-IP1840
    Target NameSTARD3NL
    Gene ID83930,76205,291182,705212,483257,101092753,510042,100051143
    Gene Symbol and Synonyms0610035N01Rik,6530409L22Rik,MENTHO,STARD3NL
    Uniprot AccessionO95772
    Uniprot Entry NameSTR3N_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000010270
    Target ClassificationN/A

    The target: STARD3NL, gene name: STARD3NL, also named as MENTHO. This gene encodes a late-endosomal protein that contains a conserved MENTAL (MLN64 N-terminal) domain. The encoded protein binds cholesterol molecules and may play a role in endosomal cholesterol transport through interactions with metastatic lymph node protein 64 (MLN64). [provided by RefSeq, Sep 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.